The Onco'Zine Brief

In this episode of the Onco’Zine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Col. James E. Williams who, during the annual meeting of the American Association for Cancer Research (AACR), held April 14 - 18, 2018 in Chicago, Ill, received the organization's Distinguished Public Service Award for Exceptional Leadership in Cancer Advocacy. Each year, the American Association for Cancer R...

In this edition of The Onco’Zine Brief Peter Hofland and Sonia Portillo are talking with Elizabeth M. Jaffee, MD, the 2018 - 2019 president of the American Association​ for Cancer Research (AACR). Dr. Jaffee’s, who's research is focused on the development of immune based therapies for pancreatic and breast cancers, is the deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Ho...

This week in The Onco’Zine Brief: Peter Hofland, Ph. D and Sonia Portillo talk with Otis Brawley, MD, MACP the Chief Medical and Scientific Officer of the American Cancer Society. Hofland and Portillo ask Dr. Brawley about the past, present, and future of the fight against cancer, including screening, diagnostics and treatment with novel, targeted drugs, and the role of the American Cancer Society...

Today in The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with Dr. Michael Caligiuri., MD The Interview was recorded during the 2018 annual meeting of American Association​ for Cancer Research (AACR) held April 14-18th, 2018 in Chicago, Illinois. Michael A. Caligiuri is a renowned physician-scientist known for his work in immunology that is focused on human natural killer cells and their...

Today in the OncoZine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Jim Ratcliff, CEO of Chairman of Rowpar Pharmaceuticals, the developer, manufacturer and marketer of best-in-class oral care products, sold under the CloSYS brand in Australia and the United States and under private label in Europe and India. In their interview with Dr. Ratcliff, Hofland and Portillo ask about the impor...

The Netherlands-born writer Manon Rinsma is the author of a new book called “13 Diamonds – Life before death from a Child’s Perspective. In her book, Rinsma writes about losing her mother at a very young age - something so traumatic that it completely changed how she viewed the world. Rinsma's mother died of a form of brain cancer. For her remaining family - finding an answer to the question "how...

In this Edition of the OncoZine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Amit Kumar, Ph. D, Chairman, President & Chief Executive Officer of ITUS Corporation Executive Chairman of Anixa Diagnostics Corporation Dr. Kumar, is the inventor of the company’s Cchek™ technology for the early detection of tumor-based cancers and has been an investor, founder, director and CEO of several te...

In this episode of The Onco'Zine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Dr. Joseph M. Connors, MD., FRCPC, Clinical Professor in the Department of Medicine, Division of Medical Oncology, at the University of British Columbia and the chair of the Lymphoma Tumor Group for the British Columbia Cancer Agency. Dr. Connors is also the lead investigator of the ECHELON-1 clinical trial,...

In this episode of The OncoZine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Thomas Yankeelov, Ph. D, a computational biomedical engineer who came to The University of Texas at Austin from Vanderbilt University, where he served as the Ingram Professor of Cancer Research; professor of radiology and radiological sciences, physics, biomedical engineering and cancer biology; and director o...

In this edition of The OncoZine Brief, Peter Hofland, Ph. D and Sonia Portillo talk Sean McCarthy, D.Phil, President and Chief Executive Officer of CytomX, a biotechnology company developing a novel 'Probody Platform' which allows them to design therapeutic drugs that selectively activate in the tumor microenvironment while reducing drug activity in healthy tissue and in circulation. In addition t...

In this episode of The OncoZine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Gisela Schwab, MD, President, Product Development and Medical Affairs and Chief Medical Officer at Exelixis. Following early work in model genetic systems, Exelixis, a genomics-based drug discovery company located in South San Francisco, CA, established a broad drug discovery and development platform that has...

In this episode of The Onco’Zine Brief Peter Hofland, Ph. D and Sonia Portillo are speaking with Joshua A. Hill, MD, an Associate in Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Center in Seattle Washington. Dr. Hill is also an attending physician at the Seattle Cancer Care Alliance, as well as an Assistant Professor at the University of Washington. In today's show Hofland and...

In this edition of The OncoZine Brief, Peter Hofland, Ph. D and Sonia Portillo review some of the interesting studies presented at the 59th annual meeting of the American Society of Hematology – which took place December 9 – 12, 2017 in Atlanta, Georgia. They recap one of the most important healthcare conferences of the year, the annual meeting American Society of Hematology or ASH, one of these ‘...

In this Edition of The OncoZine Brief, brought to you from the 59th annual meeting of the American Society of Hematology held December 9-12, 2017 in Atlanta, Georgia, Peter Hofland, Ph. D and Sonia Portillo, B.Sc, the team behind the show, sat down with Phil Rowlands, Head, Oncology Therapeutic Area Unit, Takeda, in Cambridge, Massachusetts, United States. Takeda is a global, research and developm...

For this edition of The Onco'Zine Brief, recorded during 59th annual meeting of the American Society of Hematology held December 9 to 12, 2017 in Atlanta, Georgia, Peter Hofland and Sonia Portillo, the team behind show, sat down with Steven E. Benner, M.D., Senior Vice President and Therapeutic Area Head for Oncology at Astellas Pharma. In this interview Hofland and Portillo asks Benner about the...

In this edition of The Onco'Zine Brief, recorded during the 59th annual meeting of the American Society of Hematology - held December 9 to 12, 2017 in Atlanta, Georgia (USA), we talk with Anna Sureda, MD, Ph. D, Head of the Hematology Department at the Catalan Institute of Oncology, Barcelona, Spain - to discuss some of the exciting developments in the treatment of patients with Hodgkin’s lymphoma...

In this episode Peter Hofland and Sonia Portillo, the team behind The Onco'Zine Brief, talk with Angela M. DeMichele, MD MSCE, Professor of Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania. Over the last 25 years, there has been an explosion of new and vitally important, anticancer drugs. The development of these promising new therapeutic agents is gen...

In this episode of The OncoZine Brief Peter Hofland interviews Darrin Uecker and Richard Nuccitelli of Pulse Biosciences. The team at Pulse Biosciences has developed a technology is called Nano-pulse Stimulation, or NPS. This novel technology delivers ultra-short nanosecond pulses to stimulate cellular responses in targeted tissue. These pulses induce cells to die in a natural way. Preclinical stu...

In this episode of The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with Michael A. Caligiuri, MD, the current (2017- 2018) president of the American Association for Cancer Research | AACR. Caligiuri is director of The Ohio State University Comprehensive Cancer Center and CEO of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, located in Columbus, Ohio. He is...

Born and raised in Curaçao NA, an island in the southern Caribbean Sea, Bob Pinedo, MD, PhD, now professor emeritus and a consultant to the Board of the Free University Medical Center in Amsterdam, The Netherlands, remains a real powerhouse in the World of Oncology. He has spent more than 40 years researching cancer biology, drug treatment and resistance, and it can be said that his accomplishment...

In this episode of The Onco'Zine Brief Peter Hofland and Sonia Portillo interview Nancy Brinker, founder of Susan G. Komen for the Cure. This program was originally recorded during the Annual Meeting of the American Association of Cancer Research - (AACR), held April 16 – 20, 2016, in New Orleans, Louisiana. It can be said that Nancy Brinker embodies the global movement to end breast cancer. Over...

Recorded during the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), Peter Hofland and Sonia Portillo, the team behind The Onco'Zine Brief, interview Dr. Robert Andtbacka, associate professor in the Division of Surgical Oncology, at the Department of Surgery at the University of Utah School of Medicine, and surgeon and investigator with the Intermountain Healthcare and Hunt...

Patients living with invasive breast cancer with high levels of HER3 may face a significantly worse prognosis and decreased survival. This represents a large unmet medical need. Overexpression of epidermal growth factor receptors, also known as EGFR, such as HER2 and HER3, can play a role in cancer cell development, including breast cancer. Statistics show that one in five breast cancers overexpre...

For this edition of The OncoZine Brief, Peter Hofland and Sonia Portillo sat down with Jonathan E. Lim, M.D. co-founder of IGNYTA, and its President and Chief Executive Officer since July 2012. Lim is the Founder and Managing Partner at City Hill Ventures, a company he founded in 2010. He is also a Co-Founder of Bonti, Eclipse Therapeutics and served as the Chief Executive Officer and President of...

Recorded during the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), held June 2 - 6, 2017 in Chicago, Ill, Sonia Portillo and Peter Hofland, the team behind The Onco'Zine Brief, interview Dr. Steve Benner – Senior Vice President and Therapeutics Area Head of Oncology at Astellas Pharmaceuticals, and Mark Reisenauer, Senior Vice President, Oncology business unit at Astellas...